The global microparticles market is forecast to grow at a CAGR of 10.2%, reaching USD 2.6 billion in 2031 from USD 1.6 billion in 2026.
Microparticles are solid particles composed of synthetic or natural polymers and typically are in the order of micrometers in size (1–1000 ?m). It can be prepared by dispersing, entrapping, encapsulating, or suspending the active drug within the polymer matrix. This method of encapsulation of drug and polymer leads to a more appropriate variation of the type of microparticles depending upon the drug to be encapsulated and the choice of the polymer.
Moreover, microspheres are microparticles with a wide spherical surface-to-volume ratio and homogeneously entrapping the drug in the matrix. They can also be categorized into solid and hollow types. Since the improved targeted efficiency, magnetic microspheres have also been explored for targeted drug delivery, particularly magnetic-targeted chemotherapy.
Microparticles in pharmaceutical and drug delivery provide innovative solutions in the controlled and targeted release of drugs, ensuring high therapeutic outcomes. The encapsulation of drugs by microparticles ensures that such drugs are released in a sustained manner and also helps in delaying their release, thus allowing for the maintenance of a steady concentration of the drug in the bloodstream for longer periods. Targeted delivery is also made possible by microparticles for directing drugs to specific tissues or cells in treatments like cancer, minimizing side effects on healthy tissues. For instance, 1,777,566 new cancer cases were reported in 2021 in the United States.
Moreover, these microparticles protect vulnerable molecules like proteins and mRNA from degradation for effective delivery to intended sites. Of the various biodegradable polymers most used within the framework of microparticle systems, PLGA is safe and biocompatible. It is significantly finding notable importance in pulmonary drug delivery: Formulations that are inhalable help deliver drugs efficiently in disease treatment related to the respiratory system and reduce systemic exposure with higher precision.
Microparticles are paving the way for innovative improvements in drugs in material science and even environmental technologies. In drug delivery systems, it is controlling targeted therapies and effectively improves cancer conditions. Material science is researching advanced, lightweight composites applied in the automotive and aerospace industries. Apart from its value in biological science, microparticles also play a considerable role in environmental science. Its applications can be seen in water treatment, making it easier to remove contaminants. Comprehensively, microparticle research and development boost current progress in healthcare, industrial materials, and environmental sustainability.
By application, the automotive industry is anticipated to be one of the fastest-growing segments in the microparticles market.
The automotive industry is one of the fastest-growing sectors in the microparticles market. This is because of the rising need for advanced materials that will help in making vehicles lighter and stronger with improved safety. Thus, following this, in 2021, German manufacturers produced more than 15.6 million units of automobiles, as reported by GTAI (Germany Trade & Invest). This signifies that Germany is the largest automotive manufacturing industry in Europe.
Similarly, in April 2024, the total production of passenger cars, three-wheelers, two-wheelers, and quadricycles was 23,58,041. According to the India Brand Equity Fund, passenger cars, CVs, three-wheelers, two-wheelers, and quadricycles produced in the fiscal year 2024 totaled 2,84,34,742.
The industry is shifting towards electrical, which has increased market competition concerning innovative materials containing microparticles for boosting performance, thermal management, and battery’s energy efficiency. The surge in automobile development related to autonomous and connected vehicles forms a new direction for microparticle applications in sensors, electronics, and smart surfaces through the automotive business. Still, it is considered a core part of the growing market of microparticles.
Asia Pacific’s microparticles market is anticipated to grow significantly.
The Asia Pacific microparticles market is anticipated to expand at a rapid rate, driven by rapid urbanization and demand for advanced technologies across diversified industries. The pharmaceutical industries in China and India are some of the prime growth drivers, as investment in drug delivery systems and biotechnology research is on the rise. For instance, the total market size of the Indian pharma industry is expected to reach US$130 billion by 2030 and US$450 billion by 2047. Moreover, automobile manufacturing within the domestic market alone is projected to be well over 35 million automobiles in 2025 within China.
Similarly, according to the OICA data, automotive production has enhanced by 30% in India in 2021. The favorable government policies include the newly initiated PLI schemes, which include auto and auto components. The recently established innovative chemistry cell for auto manufacturing, the FAME-II Policy until 2024, and a newly launched Rs 76,000 crore PLI scheme on semiconductor manufacturing are boosting the microparticle market growth in the country.
Additionally, the automotive and electronics industries in Japan, South Korea, and China are increasingly incorporating microparticles into materials to improve performance, fuel efficiency, and durability. The region's focus on sustainability and environmental solutions also fuels the demand for microparticles in water treatment, pollution control, and green technologies. Data released by the American Institute of Architects’ (AIA) Shanghai office indicate that China is expected to construct ten cities similar to New York by 2025. Nonetheless, favorable government policies, growing R&D capabilities, and a large consumer base further contribute to the strong growth potential of the microparticle market in Asia Pacific.
In September 2024, Industrial B2B Cleantech innovator Calyxia, a certified B Corp specializing in the production of high-performance, biodegradable microcapsules, and microparticles for use in Consumer Goods, Crop Protection, and Advanced Materials, announced that it has closed a new round of funding totaling $35 million in a Series B round.
In September 2023, Evonik expanded its parenteral drug delivery solutions platform with three standard PLA-PEG di-block copolymers and a new nanoparticle formulation service using sonication technology. Based on decades of experience in the formulation of polymeric microparticles, liposomes, lipid nanoparticles, and micelles, Evonik is expanding its products and services portfolio.
Evonik
Oakwood Labs
Cospheric
Nuoryon
Bionity
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Companies |
|
The global microparticles market is analyzed into the following segments:
By Type
Hollow
Solid
By Material
Glass
Polymer
Ceramic
Fly Ash
Metallic
Others
By Application
Automotive
Aerospace
Cosmetics
Oil and Gas
Paints and Coatings
Medical Technology
Composites
Others
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Middle East and Africa
Saudi Arabia
United Arab Emirates
Rest of the Middle East and Africa
Asia-Pacific
China
India
Japan
South Korea
Taiwan
Thailand
Indonesia
Rest of Asia-Pacific